WHO ICTRP trial
Efficacy and safety of novel NK-1 antagonist, Fosaprepitant for the prevention…
JPRN-UMIN000007376 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000007376 |
|---|---|
| Public title | Efficacy and safety of novel NK-1 antagonist, Fosaprepitant for the prevention of CINV |
| Scientific title | Efficacy and safety of novel NK-1 antagonist, Fosaprepitant for the prevention of CINV - Efficacy and safety of Fosaprepitant for the prevention of CINV |
| Primary sponsor | Kobe City Medical Center General Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Patients receiving highly or moderately emetogenic agents |
| Registration date | Jan 3, 2012 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: